Navigation Links
Merit Medical Engineers to Present at Compamed 2013

South Jordan, UT (PRWEB) November 14, 2013

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy, today announced that Merit engineers will offer solutions to engineering questions at the 2013 Compamed Trade Fair taking place at the Düsseldorf Fairgrounds in Düsseldorf, Germany from November 20-22.

Merit Medical’s Engineering Manager David Keane, based at Merit’s Hypotube Center of Excellence in Galway, Ireland, will present “A discussion about hypotube laser technology.” The 10-minute presentation will be followed by a Question and Answer session and will offer information about laser technology and how it’s used in hypotube manufacturing. The discussion will be held at the Merit Medical Booth 8AL28 on Wednesday and Thursday, November 20 and 21, at 11:00 a.m.

Merit Medical’s Director of OEM Product Engineering, Dave Johnson, based in Salt Lake City, will present “Catheter Urethane Marker Bands.” The 10-minute presentation will offer information to help guide decisions about the use of urethane marker bands for catheters. The discussion will be held at the Merit Medical Booth 8AL28 on Wednesday and Thursday, November 20 and 21, at 2:00 p.m.

A professional barista will serve fresh coffee and espresso at the booth for attendees of the Customer Solution presentations. Following both sessions, Merit Medical staff will be available to discuss manufacturing capabilities available at Merit’s new hypotube Center of Excellence and its catheter marker band expertise.

More than 600 exhibitors from 39 countries and more than 16,000 visitors will attend Compamed 2013, an international trade show for the medical supplier industry. Compamed takes place in connection with Medica, the world‘s largest medical marketplace. (

For more information visit:

Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 200 individuals. Merit employs approximately 3,000 people worldwide with facilities in South Jordan, Utah; Angleton, Texas; Richmond, Virginia; Malvern, Pennsylvania; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Copenhagen, Denmark; and Rockland, Massachusetts.

Merit Medical OEM (, a division of Merit Medical Systems, supplies medical device components and innovative devices to OEM customers around the world. Merit OEM has partnered with some of the world’s largest and most successful medical device companies on products including stock components and private labeled devices, to custom kits and trays and provides customization capabilities as well as engineering and design support. Merit Medical Coatings ( manufactures medical device components including hypotube/catheter shafts, guide wire components, needles and mandrels, and works with customers on custom solutions from the design phase through finishing details including coiling, laser cutting and ablation. Merit Medical Coatings is a world leader in the application of PFOA-free, PTFE and hydrophilic coating options for bulk quantities of medical wires and tubes.

Statements contained in this release which are not purely historical, including, without limitation, statements regarding Merit's forecasted revenues, net income, financial results or anticipated acquisitions, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties such as those described in Merit's Annual Report on Form 10-K for the year ended December 31, 2012. Such risks and uncertainties include risks relating to Merit's potential inability to successfully manage growth through acquisitions, including the inability to commercialize technology acquired through completed, proposed or future transactions; product recalls and product liability claims; expenditures relating to research, development, testing and regulatory approval or clearance of Merit's products and risks that such products may not be developed successfully or approved for commercial use; greater governmental scrutiny and regulation of the medical device industry; reforms to the 510(k) process administered by the U.S. Food and Drug Administration; compliance with governmental regulations and administrative procedures; potential restrictions on Merit's liquidity or its ability to operate its business in compliance with its current debt agreements and the consequences of failing to comply with such agreements; possible infringement of Merit's technology or the assertion that Merit's technology infringes the rights of other parties; the potential of fines, penalties, or other adverse consequences if Merit's employees or agents violate the U.S. Foreign Corrupt Practices Act or other laws and regulations; laws targeting fraud and abuse in the healthcare industry; potential for significant adverse changes in, or failure to comply with, governing regulations; the effect of changes in tax laws and regulations in the United States or other countries; the administrative burden and the expense associated with the Medical Device Excise Tax; increases in the price of commodity components; negative changes in economic and industry conditions in the United States and other countries; termination or interruption of relationships with Merit's suppliers, or failure of such suppliers to perform; fluctuations in Euro and GBP exchange rates; Merit's need to generate sufficient cash flow to fund its debt obligations, capital expenditures, and ongoing operations; concentration of Merit's revenues among a few products and procedures; development of new products and technology that could render Merit's existing products obsolete; market acceptance of new products; volatility in the market price of Merit's common stock; modification or limitation of governmental or private insurance reimbursement policies; changes in health care markets related to health care reform initiatives; failure to comply with applicable environmental laws; changes in key personnel; work stoppage or transportation risks; uncertainties associated with potential healthcare policy changes which may have a material adverse effect on Merit; introduction of products in a timely fashion; price and product competition; availability of labor and materials; cost increases; fluctuations in and obsolescence of inventory; and other factors referred to in Merit's Annual Report on Form 10-K for the year ended December 31, 2012 and other materials filed with the Securities and Exchange Commission. All subsequent forward-looking statements attributable to Merit or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Actual results will differ, and may differ materially, from anticipated results. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results, and Merit assumes no obligation to update or disclose revisions to those estimates.

# # #

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Merit Sensor Systems, Inc. Introduces TR Series Pressure Sensor Product Line
2. Meritus Offering 30 HMO, PPO Plans Beginning Today
3. One of the Largest DNA Testing Companies in the World, Announces $5,000 College Merit Scholarship
4. PolyU Emeritus Professor to Be Honoured With International Optometry Award
5. BIDMCs George Tsokos, M.D., receives NIH MERIT award
6. "Rise and Shine: The Jay Demerit Story" Exclusive Showing at Slainte Irish Pub and Restaurant to Beat Cancer
7. Merit Medical Opens Hypotube Center of Excellence
8. Childrens Nationals David Wessel receives AHA Meritorious Achievement Award
9. Capability of curry component to treat disease merits US patent
10. Worldwide Medical Polymer Markets: 2013-2020
11. California Healthcare Institute to Release 2014 California Biomedical Industry Report
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... As ... Water For Empowerment ™ attracts volunteers together who want to combine talents and ... as key stakeholders in the process. The non-profit launched its first major fundraiser ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director at the Ageless ... treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, ... without the need for surgery, prescription pills, or topical foams. , “Capillus272™ Pro ...
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, a Jacksonville-based drug ... their sobriety and show through pictures what a positive difference it makes. The ... with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short ...
(Date:11/25/2015)... ... ... On November 23rd 2015 Cozy Products, a division of Bird-X ... Products explains what this means for business moving forward. , The Tri Lite heater ... model: to sell personal heaters that reduce energy consumption, are economical and keep people ...
(Date:11/25/2015)... ... 2015 , ... In an ongoing Clinical Study conducted by an independent physician, ... Angel is evaluating the efficacy of its product and its disinfection protocol. This study ... from May 2014 through October 2015 at a 360-bed, acute-care, academic medical center located ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  Today AVACEN Medical announced the issue of United ... Energy Including Blood Viscosity Adjustment ". This patent shields the company,s AVACEN 100 dry heat therapy ... Method. Photo - ... ... ...
(Date:11/25/2015)... Endo International plc (NASDAQ: ENDP ) (TSX: ENL) today ... will discuss corporate updates at the 27 th Annual ... on Wednesday, December 2, 2015 at 1 p.m. ET. ... then the link to the event. Participants should allow approximately ... the site and download any streaming media software needed to ...
(Date:11/25/2015)... NEW YORK , November 25, 2015 ... global market of self-monitoring blood glucose devices was valued ... to grow with a CAGR of 5.7% during 2015 ... increasing geriatric population and increasing prevalence of diabetes. In ... about diabetes care is also contributing to the growth ...
Breaking Medicine Technology: